{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:27:11Z","timestamp":1782743231433,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC3043514"],"award-info":[{"award-number":["2023YFC3043514"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2303100"],"award-info":[{"award-number":["2022YFC2303100"]}]},{"name":"Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["ZYCXTD2023002"],"award-info":[{"award-number":["ZYCXTD2023002"]}]},{"name":"Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["QNCXTD2023002"],"award-info":[{"award-number":["QNCXTD2023002"]}]},{"name":"Young and middle-aged academic leaders of Henan Provincial Health Commission","award":["HNSWJW-2022013"],"award-info":[{"award-number":["HNSWJW-2022013"]}]},{"name":"University Science and Technology Innovation Talent Support Plan of Henan Province","award":["24HASTIT063"],"award-info":[{"award-number":["24HASTIT063"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10643-w","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T19:30:51Z","timestamp":1740511851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Benchen","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"1","key":"10643_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ki.2008.107","volume":"74","author":"CY Hsu","year":"2008","unstructured":"Hsu CY, Ordonez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008;74(1):101\u20137. https:\/\/doi.org\/10.1038\/ki.2008.107.","journal-title":"Kidney Int"},{"issue":"5","key":"10643_CR2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96(5):1048\u201350. https:\/\/doi.org\/10.1016\/j.kint.2019.07.012.","journal-title":"Kidney Int"},{"issue":"5","key":"10643_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442\u20138. https:\/\/doi.org\/10.1038\/ki.2011.379.","journal-title":"Kidney Int"},{"key":"10643_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00820-6","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024. https:\/\/doi.org\/10.1038\/s41581-024-00820-6.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10643_CR5","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1503\/cmaj.080351","volume":"179","author":"A Levin","year":"2008","unstructured":"Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al. Guidelines for the management of chronic kidney disease. CMAJ. 2008;179(11):1154\u201362. https:\/\/doi.org\/10.1503\/cmaj.080351.","journal-title":"CMAJ"},{"key":"10643_CR6","unstructured":"Organization WH. Coronavirus disease (COVID-19) Weekly epidemiological update and Weekly operational update, 2020. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports\/. 2020."},{"issue":"10223","key":"10643_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"Lancet"},{"issue":"1","key":"10643_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000519530","volume":"146","author":"M Brogan","year":"2022","unstructured":"Brogan M, Ross MJ. The impact of chronic kidney disease on outcomes of patients with COVID-19 admitted to the Intensive Care Unit. Nephron. 2022;146(1):67\u201371. https:\/\/doi.org\/10.1159\/000519530.","journal-title":"Nephron"},{"issue":"12","key":"10643_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41581-020-00349-4","volume":"16","author":"RT Gansevoort","year":"2020","unstructured":"Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol. 2020;16(12):705\u20136. https:\/\/doi.org\/10.1038\/s41581-020-00349-4.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10643_CR10","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.52225\/narra.v2i3.92","volume":"2","author":"K Sharun","year":"2022","unstructured":"Sharun K, Tiwari R, Yatoo MI, Natesan S, Megawati D, Singh KP, et al. A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19. Narra J. 2022;2(3):e92. https:\/\/doi.org\/10.52225\/narra.v2i3.92.","journal-title":"Narra J"},{"key":"10643_CR11","doi-asserted-by":"publisher","unstructured":"Dhama K, Nainu F, Frediansyah A, Yatoo MI, Mohapatra RK, Chakraborty S, et al. Global emerging Omicron variant of SARS-CoV-2: impacts, challenges and strategies. J Infect Public Health. 2023;16(1). https:\/\/doi.org\/10.1016\/j.jiph.2022.11.024.","DOI":"10.1016\/j.jiph.2022.11.024"},{"issue":"2","key":"10643_CR12","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.52225\/narra.v4i2.919","volume":"4","author":"R Yunita","year":"2024","unstructured":"Yunita R, Wahyuni AS, Sinaga BY, Yamamoto Z, Soebandrio A, Kusumawati RL, et al. Role of ACE2 and TMPRSS2 polymorphisms on COVID-19 outcome and disease severity in adult patients: a prospective cohort study in a tertiary hospital, Indonesia. Narra J. 2024;4(2):e919. https:\/\/doi.org\/10.52225\/narra.v4i2.919.","journal-title":"Narra J"},{"key":"10643_CR13","unstructured":"China, NHCotPsRo. COVID-19 diagnosis and treatment plan (trial version 9). https:\/\/www.govcn\/zhengce\/zhengceku\/2022-03\/15\/5679257\/files\/49854a49c7004f4ea9e622f3f2c568d8pdf. 2022."},{"key":"10643_CR14","unstructured":"China NHCotPsRo. COVID-19 diagnosis and treatment plan (trial version 10). https:\/\/www.govcn\/zhengce\/zhengceku\/2023-01\/06\/5735343\/files\/5844ce04246b431dbd322d8ba10afb48pdf. 2023."},{"issue":"51","key":"10643_CR15","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.15585\/mmwr.mm7251a2","volume":"72","author":"PR Harrington","year":"2023","unstructured":"Harrington PR, Cong J, Troy SB, Rawson JMO, O\u2019Rear JJ, Valappil TI, et al. Evaluation of SARS-CoV-2 RNA Rebound after Nirmatrelvir\/Ritonavir Treatment in Randomized, Double-Blind, placebo-controlled trials - United States and International sites, 2021\u20132022. MMWR Morb Mortal Wkly Rep. 2023;72(51):1365\u201370. https:\/\/doi.org\/10.15585\/mmwr.mm7251a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"15","key":"10643_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral nirmatrelvir for High-Risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397\u2013408. https:\/\/doi.org\/10.1056\/NEJMoa2118542.","journal-title":"N Engl J Med"},{"issue":"19","key":"10643_CR17","doi-asserted-by":"publisher","first-page":"e2001435","DOI":"10.1002\/advs.202001435","volume":"7","author":"Z Ren","year":"2020","unstructured":"Ren Z, Luo H, Yu Z, Song J, Liang L, Wang L, et al. A randomized, Open-Label, controlled clinical trial of azvudine tablets in the treatment of mild and common COVID-19, a pilot study. Adv Sci (Weinh). 2020;7(19):e2001435. https:\/\/doi.org\/10.1002\/advs.202001435.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10643_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41392-021-00835-6","volume":"6","author":"JL Zhang","year":"2021","unstructured":"Zhang JL, Li YH, Wang LL, Liu HQ, Lu SY, Liu Y, et al. Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients. Signal Transduct Target Ther. 2021;6(1):414. https:\/\/doi.org\/10.1038\/s41392-021-00835-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10643_CR19","doi-asserted-by":"publisher","first-page":"e28756","DOI":"10.1002\/jmv.28756","volume":"95","author":"G Deng","year":"2023","unstructured":"Deng G, Li D, Sun Y, Jin L, Zhou Q, Xiao C, et al. Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: a retrospective cohort study. J Med Virol. 2023;95(4):e28756. https:\/\/doi.org\/10.1002\/jmv.28756.","journal-title":"J Med Virol"},{"key":"10643_CR20","doi-asserted-by":"publisher","first-page":"105659","DOI":"10.1016\/j.antiviral.2023.105659","volume":"216","author":"H Cai","year":"2023","unstructured":"Cai H, Yan J, Liu S, Li P, Ding L, Zhan Y, et al. Paxlovid for hospitalized COVID-19 patients with chronic kidney disease. Antiviral Res. 2023;216:105659. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105659.","journal-title":"Antiviral Res"},{"key":"10643_CR21","unstructured":"SERVICES USDOHAH. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. https:\/\/www.ctepcancergov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7pdf. 2017."},{"issue":"7","key":"10643_CR22","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.apsb.2024.03.032","volume":"14","author":"N Sheng","year":"2024","unstructured":"Sheng N, Li R, Li Y, Wang Z, Wang L, Li Y, et al. Selectively T cell phosphorylation activation of azvudine in the thymus tissue with immune protection effect. Acta Pharm Sinica B. 2024;14(7):3140\u201354. https:\/\/doi.org\/10.1016\/j.apsb.2024.03.032.","journal-title":"Acta Pharm Sinica B"},{"issue":"8","key":"10643_CR23","doi-asserted-by":"publisher","first-page":"e29007","DOI":"10.1002\/jmv.29007","volume":"95","author":"S Shang","year":"2023","unstructured":"Shang S, Fu B, Geng Y, Zhang J, Zhang D, Xiao F, et al. Azvudine therapy of common COVID-19 in hemodialysis patients. J Med Virol. 2023;95(8):e29007. https:\/\/doi.org\/10.1002\/jmv.29007.","journal-title":"J Med Virol"},{"issue":"3","key":"10643_CR24","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.52225\/narra.v2i3.93","volume":"2","author":"E Mutiawati","year":"2022","unstructured":"Mutiawati E, Kusuma HI, Fathima R, Syahrul S, Musadir N. A comparison study of headache characteristics and headache-associated quality-of-life of COVID-19 and non-COVID-19 patients. Narra J. 2022;2(3):e93. https:\/\/doi.org\/10.52225\/narra.v2i3.93.","journal-title":"Narra J"},{"issue":"6","key":"10643_CR25","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.kint.2020.10.004","volume":"98","author":"Y Azzi","year":"2020","unstructured":"Azzi Y, Parides M, Alani O, Loarte-Campos P, Bartash R, Forest S, et al. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney Int. 2020;98(6):1559\u201367. https:\/\/doi.org\/10.1016\/j.kint.2020.10.004.","journal-title":"Kidney Int"},{"issue":"4","key":"10643_CR26","doi-asserted-by":"publisher","first-page":"e2551","DOI":"10.1002\/rmv.2551","volume":"34","author":"B Amani","year":"2024","unstructured":"Amani B, Amani B. Azvudine versus Paxlovid in COVID-19: a systematic review and meta-analysis. Rev Med Virol. 2024;34(4):e2551. https:\/\/doi.org\/10.1002\/rmv.2551.","journal-title":"Rev Med Virol"},{"issue":"1","key":"10643_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12985-024-02316-y","volume":"21","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xie H, Wang L, Fan J, Zhang Y, Pan S, et al. Effectiveness of azvudine in reducing mortality of COVID-19 patients: a systematic review and meta-analysis. Virol J. 2024;21(1):46. https:\/\/doi.org\/10.1186\/s12985-024-02316-y.","journal-title":"Virol J"},{"issue":"6","key":"10643_CR28","doi-asserted-by":"publisher","first-page":"e0298772","DOI":"10.1371\/journal.pone.0298772","volume":"19","author":"B Amani","year":"2024","unstructured":"Amani B, Amani B. Effectiveness and safety of azvudine in COVID-19: a systematic review and meta-analysis. PLoS ONE. 2024;19(6):e0298772. https:\/\/doi.org\/10.1371\/journal.pone.0298772.","journal-title":"PLoS ONE"},{"issue":"6","key":"10643_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jinf.2022.10.002","volume":"85","author":"H Cai","year":"2022","unstructured":"Cai H, Yan J, Wang J, Che X, Mou S. Efficacy of Paxlovid in patients with acute kidney injury who developed COVID-19. J Infect. 2022;85(6):702\u201369. https:\/\/doi.org\/10.1016\/j.jinf.2022.10.002.","journal-title":"J Infect"},{"issue":"11","key":"10643_CR30","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.ekir.2022.08.026","volume":"7","author":"A Devresse","year":"2022","unstructured":"Devresse A, Sebastien B, De Greef J, Lemaitre F, Boland L, Haufroid V, et al. Safety, Efficacy, and relapse of Nirmatrelvir-Ritonavir in kidney transplant recipients infected with SARS-CoV-2. Kidney Int Rep. 2022;7(11):2356\u201363. https:\/\/doi.org\/10.1016\/j.ekir.2022.08.026.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10643_CR31","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1053\/j.ajkd.2022.01.001","volume":"79","author":"S Fishbane","year":"2022","unstructured":"Fishbane S, Hirsch JS, Nair V. Special considerations for Paxlovid Treatment among Transplant recipients with SARS-CoV-2 infection. Am J Kidney Dis. 2022;79(4):480\u20132. https:\/\/doi.org\/10.1053\/j.ajkd.2022.01.001.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10643_CR32","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1016\/j.apsb.2023.08.001","volume":"13","author":"S Lei","year":"2023","unstructured":"Lei S, Guo A, Lu J, Qi Q, Devanathan AS, Zhu J, et al. Activation of PXR causes drug interactions with paxlovid in transgenic mice. Acta Pharm Sin B. 2023;13(11):4502\u201310. https:\/\/doi.org\/10.1016\/j.apsb.2023.08.001.","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"10643_CR33","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/aps.2012.136","volume":"33","author":"XG Meng","year":"2012","unstructured":"Meng XG, Guo CX, Feng GQ, Zhao YC, Zhou BT, Han JL, et al. Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China. Acta Pharmacol Sin. 2012;33(12):1563\u201370. https:\/\/doi.org\/10.1038\/aps.2012.136.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10643_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/aps.2015.163","volume":"37","author":"X Luo","year":"2016","unstructured":"Luo X, Zhu LJ, Cai NF, Zheng LY, Cheng ZN. Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5(*)3 genotype in Chinese renal transplant recipients. Acta Pharmacol Sin. 2016;37(4):555\u201360. https:\/\/doi.org\/10.1038\/aps.2015.163.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10643_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846\u20138. https:\/\/doi.org\/10.1007\/s00134-020-05991-x.","journal-title":"Intensive Care Med"},{"issue":"3","key":"10643_CR36","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41423-020-00557-9","volume":"18","author":"S Varchetta","year":"2021","unstructured":"Varchetta S, Mele D, Oliviero B, Mantovani S, Ludovisi S, Cerino A, et al. Unique immunological profile in patients with COVID-19. Cell Mol Immunol. 2021;18(3):604\u201312. https:\/\/doi.org\/10.1038\/s41423-020-00557-9.","journal-title":"Cell Mol Immunol"},{"issue":"7816","key":"10643_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","volume":"583","author":"X Zhang","year":"2020","unstructured":"Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020;583(7816):437\u201340. https:\/\/doi.org\/10.1038\/s41586-020-2355-0.","journal-title":"Nature"},{"issue":"6","key":"10643_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, et al. The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023;21(6):361\u201379. https:\/\/doi.org\/10.1038\/s41579-023-00878-2.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10643_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, Consortium C-GU, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21(3):162\u201377. https:\/\/doi.org\/10.1038\/s41579-022-00841-7.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10643_CR40","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.52225\/narra.v2i3.88","volume":"2","author":"SG Viveiros-Rosa","year":"2022","unstructured":"Viveiros-Rosa SG, Mendes CD, Farf\u00e1n-Cano GG, El-Shazly M. The race for clinical trials on Omicron-based COVID-19 vaccine candidates: updates from global databases. Narra J. 2022;2(3):e88. https:\/\/doi.org\/10.52225\/narra.v2i3.88.","journal-title":"Narra J"},{"issue":"1","key":"10643_CR41","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1038\/s41467-023-39638-4","volume":"14","author":"EE Goldberg","year":"2023","unstructured":"Goldberg EE, Lin Q, Romero-Severson EO, Ke R. Swift and extensive Omicron outbreak in China after sudden exit from \u2018zero-COVID\u2019 policy. Nat Commun. 2023;14(1):3888. https:\/\/doi.org\/10.1038\/s41467-023-39638-4.","journal-title":"Nat Commun"},{"issue":"2","key":"10643_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/d41591-023-00001-1","volume":"29","author":"B Cowling","year":"2023","unstructured":"Cowling B. The impact of ending \u2018zero COVID\u2019 in China. Nat Med. 2023;29(2):302. https:\/\/doi.org\/10.1038\/d41591-023-00001-1.","journal-title":"Nat Med"},{"key":"10643_CR43","unstructured":"China NHCotPsRo. Transcript of the press conference held by the Joint Prevention and Control Mechanism of the State Council of China on November 29. 2022. http:\/\/www.nhc.gov.cn\/xcs\/s3574\/202211\/6fedb556a9324cd3b5b986446ee7ca34.shtml (2022). Accessed November 29, 2022."},{"key":"10643_CR44","unstructured":"China NHCotPsRo. COVID-19 vaccination status. http:\/\/www.nhc.gov.cn\/xcs\/yqjzqk\/202211\/273b32f9a5ed4f9280f24e9ceefbab1d.shtml (2022). Accessed November 29, 2022."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10643-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10643-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10643-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T19:31:00Z","timestamp":1740511860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10643-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10643"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10643-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"13 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of The First Affiliated Hospital of Zhengzhou University approved this study (2023-KY-0865-001). Considering that this study was a retrospective study, and all patients were anonymous, the ethics committee of the First Affiliated Hospital of Zhengzhou University waived individual informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}